John W. Zinckgraf

Rationally Engineered Therapeutic Proteins with Reduced Immunogenicity

Shabnam Tangri, Bianca R. Mothé, Julie Eisenbraun et al. · The Journal of Immunology · 2005 · 166 citations

Histocompatibility, Chronic Administration, Immunology +18

Modulating gene expression using DNA vaccines with different 3′-UTRs influences antibody titer, seroconversion and cytokine profiles

John W. Zinckgraf, Lawrence K. Silbart · Vaccine · 2003 · 33 citations

Immunology, Immune Regulation, Immunodominance +17

Non-toxic Pseudomonas aeruginosa exotoxin A expressing the FMDV VP1 G-H loop for mucosal vaccination of swine against foot and mouth disease virus

Sreerupa Challa, Roger W. Barrette, Debra Rood et al. · Vaccine · 2007 · 14 citations

Mucosal Vaccination, Pathogenesis, Virology +7

Identification of HLA class II H5N1 hemagglutinin epitopes following subvirion influenza A (H5N1) vaccination

John W. Zinckgraf, Margaret Sposato, Veronica Zielinski et al. · Vaccine · 2009 · 10 citations

Vaccination, Vaccine Target, Hla Immunogenetics +6